Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001711279-26-000016
Filing Date
2026-02-17
Accepted
2026-02-17 07:05:57
Documents
85
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K krys-20251231.htm   iXBRL 10-K 2226973
2 EX-21.1 a4q25krysex211.htm EX-21.1 1158
3 EX-23.1 a4q25krysex231.htm EX-23.1 1917
4 EX-31.1 a4q25krysex311.htm EX-31.1 11462
5 EX-31.2 a4q25krysex312.htm EX-31.2 11460
6 EX-32.1 a4q25krysex321.htm EX-32.1 10955
12 krys-20251231_g1.jpg GRAPHIC 102310
13 krys-20251231_g2.jpg GRAPHIC 52240
  Complete submission text file 0001711279-26-000016.txt   10298174

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20251231.xsd EX-101.SCH 53718
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20251231_cal.xml EX-101.CAL 110926
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20251231_def.xml EX-101.DEF 279445
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20251231_lab.xml EX-101.LAB 780857
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20251231_pre.xml EX-101.PRE 522445
88 EXTRACTED XBRL INSTANCE DOCUMENT krys-20251231_htm.xml XML 1540778
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38210 | Film No.: 26636335
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)